Methodological and diagnostic relevance of IgEs to recombinant allergens Api m 1 and Ves v 5 determined by the multiplex test ImmunoCAP ISAC
- 8 June 2020
- journal article
- letter
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 50 (8) , 981-983
Abstract
Click on the article title to read more.Keywords
Funding Information
- The Slovenian Research and Innovation Agency (P3‐0360)
This publication has 9 references indexed in Scilit:
- Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposureWorld Allergy Organization Journal, 2019
- The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosisPLOS ONE, 2018
- Latex sensitization in patients with myelomeningocele: contribution of microarray techniqueEuropean Annals of Allergy and Clinical Immunology, 2018
- Cross‐sectional study on allergic sensitization of Austrian adolescents using molecule‐based IgE profilingAllergy, 2016
- EAACI Molecular Allergology User's GuidePediatric Allergy and Immunology, 2016
- Improved recombinant Api m 1‐ and Ves v 5‐based IgE testing to dissect bee and yellow jacket allergy and their correlation with the severity of the sting reactionClinical & Experimental Allergy, 2016
- Microarray evaluation of specific IgE to allergen components in elite athletesAllergy, 2012
- A new tool in the field of in-vitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP© 250 with the ImmunoCAP© ISACClinical Chemistry and Laboratory Medicine (CCLM), 2010
- Epidemiology of insect-venom anaphylaxisCurrent Opinion in Allergy and Clinical Immunology, 2008